Bowers S P, Mattar S G, Waring P J, Galloway K, Nasir A, Pascal R, Hunter J G
Department of Surgery, Emory University Hospital, Room H122, 1364 Clifton Road, Atlanta, GA 30322, USA.
Surg Endosc. 2003 Jan;17(1):49-54. doi: 10.1007/s00464-001-8155-1. Epub 2002 Oct 8.
Efforts to ablate Barrett's epithelium have met with mixed results. We report the long-term follow-up evaluation of the preliminary cohort of patients who underwent thermal ablation of Barrett's epithelium with the potassium-titanyl-phosphate (KTP) laser after anti-reflux surgery.
Nine patients with intestinal metaplasia (IM) of the esophagus underwent fundoplication (7 laparoscopic Nissen, 1 laparoscopic Toupet, 1 open Nissen) between May 1993 and October 1994. Three patients had an IM less than 3 cm long (33%). One year after the operation, all the patients were symptom free, had discontinued medications, and had a normal 24-h pH study. From June 1995 to February 1996, these patients underwent a median of two (range, 1-5) endoscopic procedures with directed mucosal ablation using the KTP laser. A comparative cohort of 21 patients (IM length, <3cm; 38%) treated during the same period with fundoplication alone served as a control. The patients were followed prospectively with annual or biennial endoscopy and biopsy. All the patients were contacted by mail, telephone, or clinic visit annually to determine symptomatic and quality-of-life outcome of antireflux surgery.
The mean follow-up period was 6.8 years (range, 6-7.5 years). At this writing, the study patients are alive and well. Eight of the patients have experienced histologic loss of IM (89%) according to their last biopsy result. One patient has had regression of low-grade dysplasia to IM. The patients treated with fundoplication alone had a mean follow-up period of 5.6 years (range, 4.7-7.2 years). On the basis of the last biopsy result, 7 of 21 patients (33%) had no evidence of IM.
A program of tailored antireflux surgery followed by thermal mucosal ablation causes a loss of IM in a majority of patients with Barrett's esophagus. This may represent a significant improvement in histologic outcome over that of treatment with fundoplication alone (p = 0.007 Fisher's exact test).
对巴雷特食管上皮进行消融的努力取得了喜忧参半的结果。我们报告了在抗反流手术后接受磷酸钛钾(KTP)激光对巴雷特食管上皮进行热消融的初步队列患者的长期随访评估。
1993年5月至1994年10月期间,9例食管肠化生(IM)患者接受了胃底折叠术(7例腹腔镜nissen术,1例腹腔镜Toupet术,1例开放nissen术)。3例患者的IM长度小于3cm(33%)。术后1年,所有患者均无症状,已停药,24小时pH监测正常。1995年6月至1996年2月,这些患者接受了中位数为两次(范围1 - 5次)的内镜检查,使用KTP激光进行定向黏膜消融。同期21例仅接受胃底折叠术治疗的患者(IM长度<3cm;38%)作为对照队列。对患者进行前瞻性随访,每年或每两年进行一次内镜检查和活检。每年通过邮件、电话或门诊对所有患者进行联系,以确定抗反流手术的症状和生活质量结果。
平均随访期为6.8年(范围6 - 7.5年)。撰写本文时,研究患者均存活且状况良好。根据他们最后一次活检结果,8例患者出现了IM的组织学消失(89%)。1例患者的低级别异型增生已消退至IM。仅接受胃底折叠术治疗的患者平均随访期为5.6年(范围4.7 - 7.2年)。根据最后一次活检结果,21例患者中有7例(33%)没有IM的证据。
先进行量身定制的抗反流手术,然后进行热黏膜消融的方案,可使大多数巴雷特食管患者的IM消失。与仅行胃底折叠术治疗相比,这可能在组织学结果上有显著改善(Fisher精确检验,p = 0.007)。